Sierra Acai Company
Sierra Acai Company
Open 7 Days a Week
MonaVie Independent Distributor
Distributor Training
Shop Online
Enroll Now
Buy Wholesale and maintain an Active status for 2 months and we will refund your $39 Distributor Fee
Friends
Buy Wholesale and maintain an Active status for 2 months and we will refund your $39 Distributor Fee
14-September-2008 18:38:50 - Apolipoprotein E Redirected from APOE4 Apolipoprotein E PDB rendering based on 1b68. Available structures: 1b68, 1bz4, 1ea8, 1gs9, 1h7i, 1le2, 1le4, 1lpe, 1nfn, 1nfo, 1or2, 1or3 Identifiers Symbols APOE; AD2; MGC1571; apoprotein External IDs OMIM: 107741 MGI: 88057 HomoloGene: 30951 Gene ontology Molecular function: beta-amyloid binding lipid transporter activity phospholipid binding lipoprotein binding heparin binding antioxidant activity tau protein binding apolipoprotein E receptor binding Cellular component: extracellular region cytoplasm chylomicron Biological process: response to reactive oxygen species cholesterol catabolic process lipid transport cellular calcium ion homeostasis induction of apoptosis cytoskeleton organization and biogenesis synaptic transmission, cholinergic learning and/or memory circulation regulation of axon extension lipoprotein metabolic process vasodilation cholesterol homeostasis intracellular transport regulation of neuronal synaptic plasticity protein tetramerization RNA expression pattern More reference expression data Orthologs Human Mouse Entrez 348 11816 Ensembl ENSG00000130203 ENSMUSG00000002985 Uniprot P02649 Q3TX45 Refseq NM_000041 mRNA NP_000032 protein NM_009696 mRNA NP_033826 protein Location Chr 19: 50.1 - 50.1 Mb Chr 7: 18.85 - 18.86 Mb Pubmed search 1 2 Apolipoprotein E APOE is an apoprotein found in the chylomicron that binds to a specific receptor on liver cells and peripheral cells. It is essential for the normal catabolism of triglyceride-rich lipoprotein constituents.1 Contents 1 Function 2 Gene 3 Alzheimer's Disease 4 References 5 Further reading 6 External links Function APOE2 is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. APOE was initially recognized for its importance in lipoprotein metabolism and cardiovascular disease. More recently, it has been studied for its role in several biological processes not directly related to lipoprotein transport, including Alzheimer's disease AD, immunoregulation, and cognition. Neonates with brain injuries and/or defects who also have abnormalities in the APOE gene may have an increased risk for cerebral palsy, according to researchers at the Northwestern University Feinberg School of Medicine. Defects in APOE result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia HLP III, in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron, VLDL and LDL remnants. APOE is 299 amino acids long and transports lipoproteins, fat-soluble vitamins, and cholesterol into the lymph system and then into the blood. It is synthesized principally in the liver, but has also been found in other tissues such as the brain, kidneys, and spleen. In the nervous system, non-neuronal cell types, most notably astroglia and microglia, are the primary producers of APOE, while neurons preferentially express the receptors for APOE. There are seven currently identified mammalian receptors for APOE which belong to the evolutionarily conserved low density lipoprotein receptor gene family. Gene The APOE gene, ApoE, is mapped to chromosome 19 in a cluster with Apolipoprotein C1 and Apolipoprotein C2. ApoE consists of four exons and three introns, totaling 3597 base pairs. The gene is polymorphic3 with three major alleles, ApoE2, ApoE3, ApoE4, which translate into three isoforms of the protein: normal - ApoE-ε3; dysfunctional - ApoE-ε2 and ApoE-ε4. These isoforms differ from each other only by single amino acid substitutions at positions 112 and 158, but have profound physiological consequences. E2 is associated with the genetic disorder type III hyperlipoproteinemia and with both increased and decreased risk for atherosclerosis. E4 has been implicated in atherosclerosis and Alzheimer's disease, impaired cognitive function, and reduced neurite outgrowth. ApoE is a target gene of liver X receptor, a nuclear receptor member that play role in metabolism regulation of cholesterol, fatty acid, and glucose homeostasis. Estimated human genotype frequency of ApoE4 Allele ε2 ε3 ε4 ε2 ∼1-2% ∼15% ∼1-2% ε3 ∼55% ∼25% ε4 ∼1-2% Alzheimer's Disease Alzheimer's Disease is characterized by plaques consisting of the peptide beta-amyloid. Apolipoprotein E enhances proteolytic break-down of this peptide, both within and between cells. Some isoforms of ApoE are not as efficient as others at catalyzing these reactions. In particular, the isoform ApoE-ε4 is not very effective, resulting in increased vulnerability to Alzheimer's in individuals with that gene variation.5 Lipidated ApoE is more effective in breaking down beta-amyloid than unlipidated ApoE. Activating liver X receptors creates more lipidated ApoE, which increases plaque removal.5 The pivotal role of ApoE in AD was first identified through linkage analysis by Margaret Pericak-Vance while working in the Roses lab at Duke University. Linkage studies were followed by association analysis confirming the role of the ApoE4 allele.6 Although 40-65% of AD patients have at least one copy of the 4 allele, ApoE4 is not a determinant of the disease - at least a third of patients with AD are ApoE4 negative and some ApoE4 homozygotes never develop the disease. Among ApoE4 carriers, another gene, GAB2, is thought to further influence the risk of getting AD.7 There is also evidence that the ApoE2 allele may serve a protective role in AD.8 Thus, the genotype most at risk for Alzheimer's disease and at earlier age is ApoE 4,4. The ApoE 3,4 genotype is at increased risk, though not to the degree that those homozygous for ApoE 4 are. The genotype ApoE 3,3 is considered at normal risk for Alzheimer's disease. The genotype ApoE 2,3 is considered at less risk for Alzheimer's disease. Interestingly, people with both a copy of the 2 allele and the 4 allele, ApoE 2,4, are at normal risk similar to the ApoE 3,3 genotype. References ^ Entrez Gene: APOE apolipoprotein E. ^ Singh PP, Singh M, Mastana SS 2002. Genetic variation of apolipoproteins in North Indians. Hum. Biol. 74 5: 673-82. PMID 12495081. ^ Singh PP, Singh M, Mastana SS 2006. APOE distribution in world populations with new data from India and the UK.. Ann.Hum. Biol. 33 3: 279-308. PMID 17092867. ^ Hill JM, Bhattacharjee PS, Neumann DM May 2007. Apolipoprotein E alleles can contribute to the pathogenesis of numerous clinical conditions including HSV-1 corneal disease. Exp Eye Res 84 5: 801-811. PMID 17007837. ^ a b Jiang Q, Lee CY, Mandrekar S, Wilkinson B, Cramer P, Zelcer N, Mann K, Lamb B, Willson TM, Collins JL, Richardson JC, Smith JD, Comery TA, Riddell D, Holtzman DM, Tontonoz P, Landreth GE 2008-06-12. ApoE promotes the proteolytic degradation of Abeta. Neuron 58 5: 681-93. United States: Cell Press. doi:10.1016/j.neuron.2008.04.010. ISSN 1097-4199. PMID 18549781. Retrieved on 2008-06-16. Lay summary - ScienceDaily 2008-06-13. ^ Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 5123: 921-3. PMID 8346443. ^ Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, Zismann VL, Joshipura KD, Pearson JV, Hu-Lince D, Huentelman MJ, Craig DW, Coon KD, Liang WS, Herbert RH, Beach T, Rohrer KC, Zhao AS, Leung D, Bryden L, Marlowe L, Kaleem M, Mastroeni D, Grover A, Heward CB, Ravid R, Rogers J, Hutton ML, Melquist S, Petersen RC, Alexander GE, Caselli RJ, Kukull W, Papassotiropoulos A, Stephan DA 2007. GAB2 Alleles Modify Alzheimer's Risk in APOE varepsilon4 Carriers 54 5: 713-720. doi:10.1016/j.neuron.2007.05.022. PMID 17553421. Free full text Free PDF Genetic data in the public domain ^ Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, Rimmler JB, Locke PA, Conneally PM, Schmader KE 1994. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7 2: 180-4. doi:10.1038/ng0694-180. PMID 7920638. Further reading Gunzburg MJ, Perugini MA, Howlett GJ. 2007. Structural basis for the recognition and cross-linking of amyloid fibrils by human apolipoprotein E.. J. Biol. Chem. 282 49: 35831-41. doi:10.1074/jbc.M706425200. PMID 17916554. Mahley RW 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.. Science 240 4852: 622-30. PMID 3283935. Strittmatter WJ, Roses AD 1995. Apolipoprotein E and Alzheimer disease.. Proc. Natl. Acad. Sci. U.S.A. 92 11: 4725-7. PMID 7761390. de Knijff P, van den Maagdenberg AM, Frants RR, Havekes LM 1995. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.. Hum. Mutat. 4 3: 178-94. doi:10.1002/humu.1380040303. PMID 7833947. Roses AD, Einstein G, Gilbert J, et al. 1996. Morphological, biochemical, and genetic support for an apolipoprotein E effect on microtubular metabolism.. Ann. N. Y. Acad. Sci. 777: 146-57. PMID 8624078. Beffert U, Danik M, Krzywkowski P, et al. 1998. The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease.. Brain Res. Brain Res. Rev. 27 2: 119-42. PMID 9622609. Mahley RW, Ji ZS 1999. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E.. J. Lipid Res. 40 1: 1-16. PMID 9869645. Mahley RW, Rall SC 2002. Apolipoprotein E: far more than a lipid transport protein.. Annual review of genomics and human genetics 1: 507-37. doi:10.1146/annurev.genom.1.1.507. PMID 11701639. Parasuraman R, Greenwood PM, Sunderland T 2002. The apolipoprotein E gene, attention, and brain function.. Neuropsychology 16 2: 254-74. PMID 11949718. Bocksch L, Stephens T, Lucas A, Singh B 2003. Apolipoprotein E: possible therapeutic target for atherosclerosis.. Current drug targets. Cardiovascular haematological disorders 1 2: 93-106. PMID 12769659. Masterman T, Hillert J 2004. The telltale scan: APOE epsilon4 in multiple sclerosis.. Lancet neurology 3 6: 331. doi:10.1016/S1474-44220400763-X. PMID 15157846. Ashford JW 2004. APOE genotype effects on Alzheimer's disease onset and epidemiology.. J. Mol. Neurosci. 23 3: 157-65. PMID 15181244. Huang Y, Weisgraber KH, Mucke L, Mahley RW 2004. Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease.. J. Mol. Neurosci. 23 3: 189-204. PMID 15181247. Itzhaki RF, Dobson CB, Shipley SJ, Wozniak MA 2004. The role of viruses and of APOE in dementia.. Ann. N. Y. Acad. Sci. 1019: 15-8. doi:10.1196/annals.1297.003. PMID 15246985. Kolovou GD, Anagnostopoulou KK 2007. Apolipoprotein E polymorphism, age and coronary heart disease.. Ageing Res. Rev. 6 2: 94-108. doi:10.1016/j.arr.2006.11.001. PMID 17224309. Lambert JC, Amouyel P 2007. Genetic heterogeneity of Alzheimer's disease: complexity and advances.. Psychoneuroendocrinology 32 Suppl 1: S62-70. doi:10.1016/j.psyneuen.2007.05.015. PMID 17659844. Raber J 2007. Role of apolipoprotein E in anxiety.. Neural Plast.: 91236. doi:10.1155/2007/91236. PMID 17710250. Ye J 2007. Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus.. PLoS Pathog. 3 8: e108. doi:10.1371/journal.ppat.0030108. PMID 17784784. Bennet AM, Di Angelantonio E, Ye Z, et al. 2007. Association of apolipoprotein E genotypes with lipid levels and coronary risk.. JAMA 298 11: 1300-11. doi:10.1001/jama.298.11.1300. PMID 17878422. Utermann G, Pruin N, Steinmetz A 1979. Polymorphism of apolipoprotein E. III. Effect of a single polymorphic gene locus on plasma lipid levels in man.. Clin. Genet. 15 1: 63-72. PMID 759055. Moriyama K, Sasaki J, Matsunaga A, et al. 1992. Apolipoprotein E1 Lys-146----Glu with type III hyperlipoproteinemia.. Biochim. Biophys. Acta 1128 1: 58-64. PMID 1356443. External links MeSH Apolipoproteins+E v d e Lipids: lipoprotein metabolism General Chylomicron - HDL - LDL - IDL - VLDL - Lpa Apolipoproteins APOA 1, 2, 5 - APOB - APOC 1, 2, 3, 4 - APOD - APOE - APOH Other Lipoprotein lipase - HDL Cholesterylester transfer protein, Acetyl-CoA C-acyltransferase, LCAT - LDL receptor - Microsomal triglyceride transfer protein - ABCA1 see also disorders Retrieved from http://en..org/wiki/Apolipoprotein_E Categories: Genes on chromosome 19 | Human proteins | Apolipoproteins | Alzheimer's disease Views Article Discussion this page History Personal tools Log in / create account Navigation Main page Contents Featured content Current events Random article Search Go Search Interaction Community portal Recent changes Contact Donate to Help Toolbox What links here Related changes Upload file Special pages Printable version Permanent link Cite this page Languages Deutsch Español РуÑ?Ñ?кий Türkçe This page was last modified on 12 August 2008, at 19:3
39 Reasons to Drink Acai Juice Every Day
What is MonaVie - Watch the 8-minute video
Discovering MonaVie Video
The Power of You Video
Effects of MonaVie Active on Antioxidant Capacity in Humans
Log into your Wholesale MonaVie Account
So many of us do not eat a balanced diet, get enough sleep, have too much stress, or are impacted with toxins and pollutants. Drinking 2 ounces of MonaVie twice a day will help your body detoxify as well as build your immune system. Its the smartest thing you can do for yourself, so start today. Buying MonaVie through our company guarantees you support 7 days a week and, if you would like to share MonaVie with your family and friends we will guide you from start to finish.
1. Click on Enroll Now (30 - 55% off retail price)
2. Pay $39 for your Wholesale ID number.
3. NO minimum order required.
4. MonaVie is delivered to your door in 3 to 5 days.